Open AccessEfficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
Author(s) -
Fahad Alsohaibani,
Mohammed N. Al-Quaiz,
Khalid Al-Kahtani,
Hamad I. Al-Ashgar,
Musthafa Peedikayil,
Abdulrahman Alfadda,
Majid A Almadi
Publication year - 2020
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_626_19
Subject(s) - medicine , helicobacter pylori , regimen , clarithromycin , gastroenterology , rapid urease test , urea breath test , metronidazole , omeprazole , amoxicillin , population , intention to treat analysis , randomized controlled trial , surgery , antibiotics , gastritis , helicobacter pylori infection , environmental health , microbiology and biotechnology , biology
The treatment efficacy of Helicobacter pylori (H. pylori) has been decreasing over time due to resistance to multiple antimicrobial therapies. The most effective treatment regimen for Saudi Arabian patients infected with H. pylori is still unknown. We aimed to study the eradication rate of 10 days of quadruple therapy; bismuth subcitrate potassium 140 mg, metronidazole 125 mg, and tetracycline 125 mg for H. pylori infection in a Saudi population.